ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2543

Content Validity of the Improved Health Assessment Questionnaire in Knee Osteoarthritis Patients

Mei Chung1, Shanshan Liu2, Zhuxuan Fu2, Lori Lyn Price3, John B. Wong4 and Chenchen Wang5, 1Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, 2Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, 3Clinical Care Research, Tufts Medical Center, Boston, MA, 4Medicine/Clinical Decision Making, Tufts Medical Center, Boston, MA, 5Rheumatology, Tufts Medical Center, Bosotn, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Health Assessment Questionnaire, Knee and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Research Methodology Poster (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:
Developed in
general population, rheumatoid arthritis and osteoarthritis patients, the Improved
Health Assessment Questionnaire (iHAQ, formerly PROMIS HAQ) assesses physical
function. The objective of this study was to evaluate the content validity of the
iHAQ in patients with knee OA.

Methods:
In a cross-sectional
analysis using the baseline data from a Tai
Chi versus physical therapy for knee osteoarthritis trial, persons meeting ACR criteria for
knee OA patients self-administered the Improved HAQ, Patient Global Health Visual
Analog Scale (Global VAS score range 0-10, 10=poor health), SF-36 survey (range
0-100, 100=good health), and WOMAC (range 0-1700, 1700=worst). We calculated two
iHAQ scores having the same score range (0-100, 100=poor function) but based on
the 20 items (method A) or 16 items (method B). To evaluate content validity, the
iHAQ was compared with Global VAS, SF-36 Physical Function and Mental Health
Component (PCS and MCS), and WOMAC pain and function using Spearman’s rank
correlation coefficients (rho). ANOVA with Bonferroni adjustment was used to test
the differences in the iHAQ scores across the tertiles of WOMAC function score.

Results:
In 204 knee OA
patients (70% female and 53% white), the mean age was 60.2 years. The median (Interquartile
Range, IQR) of iHAQ scores by the 20-item A and 16-item B methods were 21.9 (9.4,
34.4) and 18.8 (9.4, 31.3), respectively. Table 1 summarizes iHAQ scores
compared with SF-36 PCS and MCS, WOMAC pain and function, and Global VAS scores.
Both iHAQ methods A and B were significantly correlated with other measures,
with method B being slightly better. For physical function, higher iHAQ (poorer
function) was more strongly correlated with lower SF-36 PCS scores (method A: rho=-0.66, p<.0001,
method B: rho=-0.68, p<.0001)
than with higher WOMAC function score (method A: rho=0.34, p<.0001,
method B: rho=0.43, p<.0001).
The iHAQ scores also corresponded to different levels of physical function as
measured by WOMAC function (Figure 1). Higher iHAQ scores were however
only weakly correlated with higher WOMAC pain scores (method A: rho=0.26, p=.0002, method B: rho=0.295, p<.0001), lower SF-36 MCS scores
(method A: rho=-0.36, p<.0001, method B: rho=-0.37, p<.0001), and higher Global VAS scores (method
A: rho=0.28,
p<.0001, method B: rho=0.31, p<.0001).

Conclusion: The
Improved HAQ has content validity for assessing physical function in knee OA
patients. It also correlated more modestly with pain, mental health and global health
status. Investigation for its longitudinal validity (responsiveness) is
warranted.

 

Table 1.  Results of Spearman’s Rank Correlation Coefficients Analysis

Instruments

Median (IQR)

Method A

Method B

 

 

rho

P value

rho

P value

Improved HAQ method A

(0 best – 100 worst)

21.9

(9.4, 34.4)

1.0000

–

0.9756

<0.0001

Improved HAQ method B

(0 best – 100 worst)

18.8

(9.4, 31.3)

0.9756

<0.0001

1.0000

–

SF-36 PCS

(0 worst – 100 best)

36.7

(29.1, 43.5)

-0.658

<0.0001

-0.675

<0.0001

SF-36 MCS

(0 worst – 100 best)

54.6

(46.5, 59.7)

-0.355

<0.0001

-0.372

<0.0001

WOMAC Pain

(0 best – 500 worst)

239.8

(172.5, 325.3)

0.263

0.0002

0.295

<0.0001

WOMAC Function

(0 best – 1700 worst)

905.8

(623.0, 1147.3)

0.340

<0.0001

0.429

<0.0001

Global VAS

(0 good – 10 poor)

5.5

(4.7, 6.0)

0.284

<0.0001

0.306

<0.0001


Disclosure: M. Chung, None; S. Liu, None; Z. Fu, None; L. L. Price, None; J. B. Wong, None; C. Wang, None.

To cite this abstract in AMA style:

Chung M, Liu S, Fu Z, Price LL, Wong JB, Wang C. Content Validity of the Improved Health Assessment Questionnaire in Knee Osteoarthritis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/content-validity-of-the-improved-health-assessment-questionnaire-in-knee-osteoarthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/content-validity-of-the-improved-health-assessment-questionnaire-in-knee-osteoarthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology